| Ms Dianna L Varner, | |
|
1350 Dares Beach Rd, Prince Frederick, MD 20678-4207 | |
| (443) 550-8381 | |
| Not Available |
| Full Name | Ms Dianna L Varner |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1350 Dares Beach Rd, Prince Frederick, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528530425 | NPI | - | NPPES |
| 07347 | Other | MD | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 07347 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Dianna L Varner, 1350 Dares Beach Rd, Prince Frederick, MD 20678-4207 Ph: (443) 550-8381 | Ms Dianna L Varner, 1350 Dares Beach Rd, Prince Frederick, MD 20678-4207 Ph: (443) 550-8381 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the recommendation by the Data Safety Monitoring Board (DSMB) to continue with the global Phase 2b clinical trial with tamibarotene in combination with chemotherapeutical agents as a first-line treatment for patients with advanced non-small-cell lung cancer.
A new minimally invasive surgery could provide a breakthrough in treating early-stage lung cancer, based on a review of some of the first patients to receive the procedure.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.
As governments, industry and public interest groups from across the globe prepare to meet next week to discuss endocrine-disrupting chemicals and other international chemical safety issues, the Endocrine Society and IPEN released a new guide documenting the threat endocrine-disrupting chemicals (EDCs) pose to human health.
› Verified 4 days ago
Mrs. Brandi Leigh Simmons, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 Dares Beach Rd, Prince Frederick, MD 20678 Phone: 540-533-3201 | |
Allison Gardner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 Dares Beach Rd, Prince Frederick, MD 20678 Phone: 443-550-8345 | |
Mrs. Catherine M Jenifer, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1450 Dares Beach Rd, Prince Frederick, MD 20678 Phone: 410-550-9550 | |
Tara Lynn Randol, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 Dares Beach Rd, Prince Frederick, MD 20678 Phone: 443-550-8345 | |
Charlotte Betteridge, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 Dares Beach Rd, Prince Frederick, MD 20678 Phone: 443-550-8345 | |
Eileen Fitzsimmons, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 Dares Beach Rd, Prince Frederick, MD 20678 Phone: 443-550-8345 | |
Christine Conn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 Dares Beach Rd, Prince Frederick, MD 20678 Phone: 443-550-8345 |